CareRx Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA14173C1059
CAD
3.35
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

16.98 k

Shareholding (Dec 2016)

FII

0.06%

Held by 1 FIIs

DII

99.94%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Healthy long term growth as Net Sales has grown by an annual rate of 16.23%

 
2

Positive results in Jun 26

3

With ROE of 25.38%, it has a attractive valuation with a 1.90 Price to Book Value

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 213 Million (Small Cap)

stock-summary
P/E

7.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.25

stock-summary
Return on Equity

25.38%

stock-summary
Price to Book

1.93

Revenue and Profits:
Net Sales:
94 Million
(Quarterly Results - Jun 2026)
Net Profit:
0 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.47%
0%
-8.47%
6 Months
-12.76%
0%
-12.76%
1 Year
18.37%
0%
18.37%
2 Years
51.58%
0%
51.58%
3 Years
59.52%
0%
59.52%
4 Years
-9.21%
0%
-9.21%
5 Years
-50.44%
0%
-50.44%

CareRx Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
16.23%
EBIT Growth (5y)
69.67%
EBIT to Interest (avg)
0.85
Debt to EBITDA (avg)
2.05
Net Debt to Equity (avg)
0.41
Sales to Capital Employed (avg)
2.61
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
9.60%
Pledged Shares
0
Institutional Holding
0.06%
ROCE (avg)
6.06%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
7
Industry P/E
Price to Book Value
1.90
EV to EBIT
18.61
EV to EBITDA
7.68
EV to Capital Employed
1.72
EV to Sales
0.63
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
9.24%
ROE (Latest)
25.38%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2016stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.06%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -0.32% vs -2.29% in Mar 2026",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -66.67% vs -94.96% in Mar 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "93.60",
          "val2": "93.90",
          "chgp": "-0.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.40",
          "val2": "8.00",
          "chgp": "-7.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.60",
          "val2": "1.50",
          "chgp": "6.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.70",
          "val2": "-0.20",
          "chgp": "-250.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.40",
          "val2": "1.20",
          "chgp": "-66.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "31.80%",
          "val2": "36.60%",
          "chgp": "-0.48%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 0.95% vs -1.08% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 680.00% vs 16.67% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "370.20",
          "val2": "366.70",
          "chgp": "0.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "30.20",
          "val2": "26.60",
          "chgp": "13.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.80",
          "val2": "9.20",
          "chgp": "-26.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.40",
          "val2": "-2.10",
          "chgp": "33.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "26.10",
          "val2": "-4.50",
          "chgp": "680.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "32.10%",
          "val2": "20.30%",
          "chgp": "1.18%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQstock-summary

Jun'26
Mar'26
Change(%)
Net Sales
93.60
93.90
-0.32%
Operating Profit (PBDIT) excl Other Income
7.40
8.00
-7.50%
Interest
1.60
1.50
6.67%
Exceptional Items
-0.70
-0.20
-250.00%
Consolidate Net Profit
0.40
1.20
-66.67%
Operating Profit Margin (Excl OI)
31.80%
36.60%
-0.48%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2026 is -0.32% vs -2.29% in Mar 2026

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is -66.67% vs -94.96% in Mar 2026

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
370.20
366.70
0.95%
Operating Profit (PBDIT) excl Other Income
30.20
26.60
13.53%
Interest
6.80
9.20
-26.09%
Exceptional Items
-1.40
-2.10
33.33%
Consolidate Net Profit
26.10
-4.50
680.00%
Operating Profit Margin (Excl OI)
32.10%
20.30%
1.18%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 0.95% vs -1.08% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 680.00% vs 16.67% in Dec 2024

stock-summaryCompany CV
About CareRx Corp. stock-summary
stock-summary
CareRx Corp.
Pharmaceuticals & Biotechnology
CareRx Corporation (CareRx), formerly Centric Health Corporation, is a Canada-based provider of pharmacy services and solutions to home operators and residents. The Company offers a range of medication solutions. CareRx provides services in rural and urban areas throughout Ontario, Alberta, British Columbia, and parts of Saskatchewan. The Company serves long-term care, retirement and assisted living, and supportive housing and group homes. CareRx offers a range of technology and program solutions, which includes eMAR Integration, Digital Prescribing, Nursing Portal and Karie Medication Dispenser.
Company Coordinates stock-summary
Company Details
20 Eglinton Ave W , TORONTO ON : M4R 1K8
Registrar Details